key: cord-0968056-e8035rc6 authors: Kanchi, Prabhu; Sambandam, Swaminathan; Siddhan, Rajasekaran; Soundappan,; Vaseekaran, V. P.; Gupta, Ankur title: Successful kidney transplantation after COVID-19 infection in two cases date: 2021-01-09 journal: Nefrologia DOI: 10.1016/j.nefro.2020.12.004 sha: 443d64033d5ff24906385b16f1ad909635f025a2 doc_id: 968056 cord_uid: e8035rc6 nan We hereby report two successful kidney transplants done during the pandemic of COVID-19. The first case was a 44-year-old male chronic kidney disease stage 5 secondary to diabetic nephropathy on haemodialysis, with left arteriovenous fistula as vascular access, who presented with myalgias for one day. There was no associated cough, sputum, fever or loss of smell. He was diagnosed to be positive for COVID-19 reverse transcriptase polymerase chain reaction (RT-PCR, cobas® SARS-CoV-2 test, Roche Diagnostics). Subsequently, he was diagnosed to have COVID-19 pneumonia (figure 1) and was treated for same with dexamethasone, oxygen support (oxygen saturations 87% at the time of oxygen initiation) and other symptomatic treatment. He improved clinically and was tested negative for COVID-19 PCR twice over next two weeks. Subsequently, serum IgG titres against SARS-CoV-2 (done at 2 weeks after the initial diagnosis) by chemiluminescence enzyme immunoassay (CLIA, CPC Diagnostics) were positive. A deceased donor kidney was offered and a calculated and explained risk was taken considering his recent recovery from COVID-19 pneumonia and the severe nature of his condition. The patient underwent a successful deceased donor kidney transplant after 4 weeks of initial diagnosis of COVID-19 with a negative pre-operative RT-PCR for SARS-CoV-2 and did not require any additional dialysis post-transplant. Basiliximab induction with triple drug immunosuppression consisting of prednisone, tacrolimus and mycophenolate mofetil was used. His post-operative period was uneventful and was discharged with a good graft function. He Transplant nephrologists have a challenging task to choose the ideal patient who deserves a timely transplant during this pandemic. They also have the responsibility to prevent and treat COVID-19 in these recipients. COVID-19 is expected to continue for months from now with no definite cure or effective vaccine in immediate future. Kidney disease can be more deadly than COVID-19 itself in some patients. The balancing act of transplant and immunosuppression in the era of COVID-19 will be an uphill task for the Nephrology community with more lessons to be learnt. Consent: Informed and written consent has been taken from both patients. GEM Hospitals GEM Hospitals GEM Hospitals GEM Hospitals Whakatane Hospital Covid-19 and Kidney Transplantation Early Impact of COVID-19 on Transplant Center CKD is a key risk factor for COVID-19 mortality Covid-19) guidance for patients with kidney disease | Kidney Care UK COVID-19 Working Group of Indian Society of Nephrology Successful kidney transplantation after COVID-19